BPC-157, TB-500, the Wolverine Stack peptide, and other compounds discussed are sold in the United States for research purposes only and are not approved by the FDA for human therapeutic use
Research published in peptide patent literature from Diagen indicates the arginate form can achieve oral bioavailability exceeding 90%, compared to less than 3% for the acetate form
Regionally, North America and Europe lead in consumption, accounting for over 60% of the global market
Oral delivery is a natural fit for BPC-157's strengths: it was isolated from gastric juice, so when taken orally it works directly on the gut lining and GI tract, calming inflammation, supporting mucosal repair, while still providing systemic recovery support for tendons, ligaments, and connective tissue
Procedure Description Preparation: Patients consult with Balanced Medical Solutions to assess suitability for the treatment
B12 deficiency affects nerve signaling involved in balance, while low vitamin D weakens muscles and coordination, increasing fall risk
